65 I B, drugs, pharmaceuticals, & hematology related products, FSS contract award

Active Awarded Last action

Contract number
36F79721D0227
Awardee
Awarding agency
Task orders
0

Award facts

Opportunity
  • 65IB Solicitation number
Last date to order 26% complete
IDV ceiling
$225,000.00
Award type
Multiple award
Who can order
All agencies
Contracting staff
Set-aside
No set-aside
Competition
Full and Open Competition Negotiated Proposal / Quote
Pricing
Fixed Price with Economic Price Adjustment

Award details come from SAM.gov/FPDS.

About this IDV

GSA awarded a Federal Supply Schedule contract to Amivas US LLC under the Pharmaceuticals and Drugs schedule (FSS-61-IB) on August 15, 2021, with a ceiling of $225,000.00.

The contract is a multiple-award vehicle designated as Schedule 65 I B covering drugs, pharmaceuticals, and hematology-related products. It carries an evergreen status and runs through August 14, 2041. Place of performance is nationwide, with ordering activity occurring through VA medical facilities under the administering Veterans Integrated Service Network 12. The contract is not set-aside and serves as a multi-agency ordering mechanism allowing federal agencies to place task orders against Amivas's published price list for pharmaceutical and hematology products.

Amivas US LLC focuses on development, manufacturing, and commercialization of therapeutics for infectious disease treatment. The company holds exclusive U.S. manufacturing and marketing rights for Artesunate for Injection, an FDA-approved anti-malarial drug, through 2026 and has supplied this product to the Defense Health Agency under separate firm fixed price purchase orders. Amivas holds a second multiple-award interim agreement under the same GSA Pharmaceuticals and Drugs schedule with a lower ceiling value, structured to serve as an ordering mechanism pending finalization of a longer-term vehicle.

Transactions

Action Obligated Date
Supplemental Agreement for work within scope P00010 · Evergreen $0
Supplemental Agreement for work within scope P00009 · Temp K extension $0
Supplemental Agreement for work within scope P00008 · FSS $0
Supplemental Agreement for work within scope P00007 · Admin MOD revision to 2025 public law pricing update $0
Supplemental Agreement for work within scope P00006 · 2025 public law pricing update $0
Supplemental Agreement for work within scope P00005 · 2024 PL $0
Supplemental Agreement for work within scope P00004 · 42-2A 2023 public law 102-585 pricing update (dual pricing) $0
Supplemental Agreement for work within scope P00003 · 42-2A 2022 public law 102-585 pricing update (dual pricing) $0
Supplemental Agreement for work within scope P00002 · 65IB: product deletion - discontinued by the manufacturer/NDC change - 42-2A $0
Supplemental Agreement for work within scope P00001 · 65IB - NDC change - SIN 42-2A $0
Original award $0
Show all 11

Quick answers

Who was awarded contract 36F79721D0227?

36F79721D0227 was awarded to Amivas US LLC by Veterans Integrated Service Network 12 (Veterans Health Administration) on August 15, 2021.

How much is contract 36F79721D0227 worth?

36F79721D0227's own ceiling is $225,000.

Who can order from contract 36F79721D0227?

36F79721D0227 is a multiple award federal supply schedule. All agencies can place orders on it.

Is contract 36F79721D0227 part of a contract vehicle?

Yes. 36F79721D0227 is part of Pharmaceuticals and Drugs (FSS-61-IB).

Was contract 36F79721D0227 competed?

The extent of competition for 36F79721D0227 was full and open competition.

On GovTribe

See this IDV's full record

  • Every order and transaction
  • The awardee's other awards and teaming partners
  • Similar IDVs and recompete opportunities
  • Ask GovTribe AI about this IDV